Study To Examine Toxicity Of Allogeneic Stem Cell Transplantation For Relapsed Or Therapy Refractory Ewings Sarcoma
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the toxicity of using allogeneic stem cell
transplantation for treatment of subjects with relapsed or refractory ES and
rhabdomyosarcoma. This is a nanrandomized two-arm study is designed to determine the safety
and incidence of graft versus host disease (GVHD) in patients with relapsed, refractory
Ewings sarcoma receiving related and unrelated, allogeneic stem cell transplants.